FFR Versus iFR in Assessment of Hemodynamic Lesion Significance
Sponsored by General University Hospital, Prague
About this trial
Last updated 9 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 6 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Stable angina pectoris
* Age 18-80 years
* Signed inform consent
* Coronary arteries without severe tortuosity and calcifications
* Normal blood flow in coronary arteries (TIMI flow III)
* Coronary artery stenosis less than 80% during CAG
Exclusion Criteria
* Hemodynamic instability, cardio-pulmonary resuscitation in a same day
* Thrombosis in a target coronary artery visible during angiography
* Patients after or with planned coronary artery bypass grafting
* Severe bronchial asthma or atrio-ventricular block higher than first degree (contraindication for adenosine administration)
* Renal insufficiency with creatinine level more than 180 umol/l
* Known allergy to iodine contrast
* Pregnancy
